跳至主要内容
临床试验/NCT02286778
NCT02286778已完成2 期

The Eradication of Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor

Optimal Health Research0 个研究点目标入组 60 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
主要终点
Number of participants tumor free

研究概览

简要总结

The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Clinical diagnosis of breast cancer
  • Referred to the study by their treating physician

排除标准

  • Any type of treatment for breast cancer before starting the study

研究组 & 干预措施

Placebo

Placebo Comparator

Dietary Supplement: No Acetogenins BID for 12 months

干预措施: Placebo (Dietary Supplement)

Acetogenins

Active Comparator

Dietary Supplement: Acetogenins BID for 12 months

干预措施: Acetogenins (Dietary Supplement)

Control

No Intervention

Control subjects will not receive the Acetogenins or the placebo. They will be evaluated every other month to monitor disease progress.

结局指标

主要结局

Number of participants tumor free

时间窗: 12 months

assessed by MRI

次要结局

未报告次要终点

研究者

发起方
Optimal Health Research
申办方类型
Other
责任方
Sponsor

相似试验